Mario Enrico Canonico/LinkedIn
Aug 20, 2026, 13:46
Mario Enrico Canonico։ CLEAR Outcomes Analysis Highlights Bempedoic Acid Benefits in PAD
Mario Enrico Canonico, Assistant Research Professor of Medicine at University of Colorado, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Circulation, adding:
”Excited to share our analysis from the CLEAR Outcomes trial, led by Marc Bonaca, now published in Circulation!
Bempedoic acid reduced MACE and MALE in patients with PAD.”
Title: Bempedoic Acid and First and Recurrent Limb Outcomes in Statin-Intolerant Patients With Peripheral Artery Disease: Insights From the CLEAR Outcomes Trial
Authors: Marc P. Bonaca, Mario Enrico Canonico, Na Li, William J. Sasiela, Steven E. Nissen, A. Michael Lincoff, Stephen J. Nicholls
Stay updated on the latest scientific advances with Hemostasis Today.
-
Aug 20, 2026, 15:15The Cell in Your Bone Marrow Responsible for Making Platelets – ITP Support Association
-
Aug 20, 2026, 15:10Shiny K. Kajal: The Latest ISBT Blood Group Update Is Here
-
Aug 20, 2026, 14:57Spiros Denaxas: The Risk Factor Paradox in Recurrent Heart Disease
-
Aug 20, 2026, 14:44ISTH SSC Women’s Health Survey: Thromboprophylaxis in Pregnancy
-
Aug 20, 2026, 14:22Wolfgang Miesbach։ Thrombosis After Haemophilia B Gene Therapy
-
Aug 20, 2026, 14:08Ahmed Mostafa: Decoding HLA-B27 in Ankylosing Spondylitis
-
Aug 20, 2026, 14:02Rafail A. Kotronias: Improving the Detection and Management of Coronary Microvascular Obstruction
-
Aug 20, 2026, 14:00Cindy Neunert: What Matters Most to Patients with ITP
-
Aug 20, 2026, 13:34Ons Marsit: What Is the Residual Thromboembolic Risk After AF Ablation?